Filter News
Area of Research
- (-) Fusion and Fission (1)
- (-) Nuclear Science and Technology (2)
- Biological Systems (1)
- Biology and Environment (16)
- Clean Energy (6)
- Computational Biology (2)
- Computational Engineering (1)
- Isotopes (5)
- Materials (7)
- Materials for Computing (2)
- National Security (2)
- Neutron Science (11)
- Supercomputing (17)
News Type
News Topics
- (-) Biomedical (3)
- 3-D Printing/Advanced Manufacturing (7)
- Advanced Reactors (17)
- Artificial Intelligence (1)
- Bioenergy (2)
- Biology (1)
- Buildings (1)
- Chemical Sciences (4)
- Composites (1)
- Computer Science (4)
- Coronavirus (1)
- Critical Materials (1)
- Cybersecurity (1)
- Decarbonization (3)
- Energy Storage (4)
- Environment (3)
- Exascale Computing (1)
- Fossil Energy (1)
- Frontier (1)
- Fusion (30)
- Grid (2)
- High-Performance Computing (2)
- Isotopes (6)
- ITER (6)
- Materials (1)
- Materials Science (7)
- Microscopy (1)
- Molten Salt (4)
- Nanotechnology (1)
- Net Zero (1)
- Neutron Science (6)
- Nuclear Energy (61)
- Partnerships (3)
- Physics (3)
- Security (2)
- Simulation (3)
- Space Exploration (6)
- Sustainable Energy (5)
- Transformational Challenge Reactor (3)
- Transportation (2)
Media Contacts
“Three-Dimensional Breast Cancer Spheroids” submitted by radiotherapeutics researcher Debjani Pal is stunning. Brilliant blue dots pop from an electric sphere threaded with bright colors: greens, aqua, hot pink and red.
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.